GUFIC BIOSCIENCES Financial Statement Analysis
|
||
|
The Revenues of GUFIC BIOSCIENCES have decreased by 0.00% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -19.09 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]
| Consolidated | Mar2025 | Mar2024 |
|---|---|---|
| Revenues | ₹807 Cr | ₹807 Cr |
| Expenses | ₹659 Cr | ₹659 Cr |
| Operating Profit (Excl OI) | ₹147 Cr | ₹147 Cr |
| Other Income | ₹2.18 Cr | ₹2.18 Cr |
| Interest | ₹17 Cr | ₹17 Cr |
| Depreciation | ₹17 Cr | ₹17 Cr |
| Profit Before Tax | ₹116 Cr | ₹116 Cr |
| Profit After Tax | ₹86 Cr | ₹86 Cr |
| Consolidated Net Profit | ₹86 Cr | ₹86 Cr |
| Earnings Per Share (Rs) | ₹6.95 | ₹8.59 |
| PAT Margin (%) | 6.33 | 9.16 |
| ROE(%) | 12.29 | 16.17 |
| ROCE(%) | 13.48 | 15.59 |
| Total Debt/Equity(x) | 0.52 | 0.60 |
Key Financials |
||
| Market Cap | : | ₹ 3,121.3 Cr |
| Revenue (TTM) | : | ₹ 873.6 Cr |
| Net Profit(TTM) | : | ₹ 56.9 Cr |
| EPS (TTM) | : | ₹ 5.7 |
| P/E (TTM) | : | 54.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GUFIC BIOSCIENCES | -1.2% | -10.6% | -33.9% |
| SUN PHARMACEUTICAL INDUSTRIES | -5.2% | -7.6% | -8.6% |
| DIVIS LABORATORIES | -5.6% | -7.3% | 1.5% |
| CIPLA | -4.5% | -9.7% | -4.6% |
| TORRENT PHARMACEUTICALS | -0.6% | 4.8% | 25% |
| DR REDDYS LABORATORIES | -2.6% | -9.7% | -10.5% |
| MANKIND PHARMA | -6.4% | -3.4% | -16.6% |
| ZYDUS LIFESCIENCES | -0.9% | -4.8% | -11.7% |
| LUPIN | -2.5% | 0.6% | 3.2% |
GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹807 Cr | 0.00 | |
| Mar2024 | ₹807 Cr | - | |
GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹147 Cr | 0.00 | |
| Mar2024 | ₹147 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 18.26% | 0.00 | |
| Mar2024 | 18.26% | - | |
GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹86 Cr | 0.00 | |
| Mar2024 | ₹86 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -30.90 % |
| 5 Yr CAGR | -30.90 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 6.33 % | -30.90 | |
| Mar2024 | 9.16 % | - | |
GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | -19.09 % |
| 5 Yr CAGR | -19.09 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.95 | -19.09 | |
| Mar2024 | ₹8.59 | - | |
GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | -13.53 % |
| 5 Yr CAGR | -13.53 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 13.48% | -13.53 | |
| Mar2024 | 15.59% | - | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Current Share Price | : | ₹311.2 |
| Current MarketCap | : | ₹ 3,121.3 Cr |
| Updated EOD on | : | Jan 21,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -1.2% |
-10.6% |
-33.9% |
| SENSEX | -2.1% |
-3% |
6.8% |
GUFIC BIOSCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | -4.7% | -4.8% | -2.7% |
| BSE SMALLCAP | -4.9% | -5.7% | -8.2% |
You may also like the below Video Courses
FAQ about GUFIC BIOSCIENCES Financials
How the annual revenues of GUFIC BIOSCIENCES have changed ?
The Revenues of GUFIC BIOSCIENCES have decreased by 0.00% YoY .
How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -19.09 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs